NEVVI Medicare utilization intelligence
or

← back

Provider profile

PATEL, ANAND MD

Rheumatology · NPI 1669911863 · PRINCETON, NJ

1
Groups
24
Codes · 2024
25,044
Disclosed services

PATEL, ANAND is a Rheumatology in PRINCETON, NJ, a member of 1 medical group, who billed 24 distinct codes to Medicare Part B in 2024.

Groups: PRINCETON MEDICAL GROUP,P.A. (PRINCETON, NJ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

25,044
disclosed services
24
codes billed to Medicare Part B
Prior year · CY2023 11,513 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
96372 Injection of drug or substance under skin or into muscle
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
20610 Aspiration and/or injection of fluid from large joint
96413 Administration of chemotherapy into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
20550 Injection into tendon or ligament
81003 Automated urinalysis test
81001 Manual urinalysis test with examination using microscope, automated
84443 Blood test, thyroid stimulating hormone (tsh)
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.